159 related articles for article (PubMed ID: 38698687)
1. Construction and validation of "WCH-nomogram" for predicting the prognosis after resection of colorectal liver metastases.
Jiang C; Liu W; Jin Z; Lan L; Xu L; Du A; Peng S; Zeng Y; Wang H; Liao M; Zhou J
Cancer Med; 2024 May; 13(9):e7222. PubMed ID: 38698687
[TBL] [Abstract][Full Text] [Related]
2. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection.
Liu W; Wang K; Han Y; Liang JY; Li YH; Xing BC
Eur J Surg Oncol; 2019 Nov; 45(11):2070-2077. PubMed ID: 31279595
[TBL] [Abstract][Full Text] [Related]
3. A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy.
Liang JY; Lin HC; Liu J; Wang DS; Yuan YF; Li BK; Zheng Y; Wu XJ; Chen G; Wang FH; Wang ZQ; Pan ZZ; Wan DS; Xu RH; Li YH
Cancer Med; 2021 Mar; 10(5):1535-1544. PubMed ID: 33539664
[TBL] [Abstract][Full Text] [Related]
4. Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.
Margonis GA; Sasaki K; Gholami S; Kim Y; Andreatos N; Rezaee N; Deshwar A; Buettner S; Allen PJ; Kingham TP; Pawlik TM; He J; Cameron JL; Jarnagin WR; Wolfgang CL; D'Angelica MI; Weiss MJ
Br J Surg; 2018 Aug; 105(9):1210-1220. PubMed ID: 29691844
[TBL] [Abstract][Full Text] [Related]
5. A Prognostic Scoring System to Predict Survival Outcome of Resectable Colorectal Liver Metastases in this Modern Era.
Liu W; Zhang W; Xu Y; Li YH; Xing BC
Ann Surg Oncol; 2021 Nov; 28(12):7709-7718. PubMed ID: 34023948
[TBL] [Abstract][Full Text] [Related]
6. Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection.
Zhong W; Xu B; Lu Y; Chang J; Xu L; Zhao H; Che X
J Gastroenterol Hepatol; 2024 May; 39(5):908-919. PubMed ID: 38323685
[TBL] [Abstract][Full Text] [Related]
7. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
[TBL] [Abstract][Full Text] [Related]
8. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases.
Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
Br J Surg; 2016 Apr; 103(5):590-9. PubMed ID: 26780341
[TBL] [Abstract][Full Text] [Related]
9. Nomograms predicting primary lymph node metastases and prognosis for synchronous colorectal liver metastasis with simultaneous resection of colorectal cancer and liver metastases.
Yao J; Chen Q; Deng Y; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Zhao H; Cai J
Ann Palliat Med; 2021 Apr; 10(4):4220-4231. PubMed ID: 33832313
[TBL] [Abstract][Full Text] [Related]
10. [Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
An SL; Ji ZH; Li XB; Liu G; Zhang YB; Gao C; Zhang K; Zhang XJ; Yan GJ; Yan LJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):434-441. PubMed ID: 37217351
[No Abstract] [Full Text] [Related]
11. Prognostic factors in colorectal liver metastases patients with various tumor numbers treated by liver resection: a single-center, retrospective study.
Chen FL; Wang YY; Liu W; Xing BC
World J Surg Oncol; 2022 Jul; 20(1):237. PubMed ID: 35854361
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients.
Gholami S; Kemeny NE; Boucher TM; Gönen M; Cercek A; Kingham TP; Balachandran V; Allen P; DeMatteo R; Drebin J; Jarnagin W; D'Angelica M
Ann Surg; 2020 Aug; 272(2):352-356. PubMed ID: 32675549
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases.
Sakai N; Furukawa K; Takayashiki T; Kuboki S; Takano S; Ohtsuka M
BMC Cancer; 2021 Apr; 21(1):412. PubMed ID: 33858364
[TBL] [Abstract][Full Text] [Related]
14. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors differ according to KRAS mutational status: A classification and regression tree model to define prognostic groups after hepatectomy for colorectal liver metastasis.
Moro A; Mehta R; Tsilimigras DI; Sahara K; Paredes AZ; Bagante F; Guglielmi A; Alexandrescu S; Poultsides GA; Sasaki K; Aucejo FN; Pawlik TM
Surgery; 2020 Sep; 168(3):497-503. PubMed ID: 32675031
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Impact of KRAS Mutation in Patients Having Curative Resection of Synchronous Colorectal Liver Metastases.
Goffredo P; Utria AF; Beck AC; Chun YS; Howe JR; Weigel RJ; Vauthey JN; Hassan I
J Gastrointest Surg; 2019 Oct; 23(10):1957-1963. PubMed ID: 30276588
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
18. Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survival.
Okuno M; Hatano E; Seo S; Taura K; Yasuchika K; Nakajima A; Yazawa T; Furuyama H; Kawamoto H; Yagi S; Nishitai R; Fujikawa T; Arimoto A; Zaima M; Yoshimura T; Terajima H; Kaihara S; Manaka D; Tanaka A; Uemoto S
J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):881-8. PubMed ID: 25155418
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis.
Ono K; Abe T; Oshita A; Sumi Y; Yano T; Okuda H; Kurayoshi M; Kobayashi T; Ohdan H; Noriyuki T; Nakahara M
World J Surg Oncol; 2021 Apr; 19(1):97. PubMed ID: 33820549
[TBL] [Abstract][Full Text] [Related]
20. Performance of prognostic models incorporating KRAS mutation status to predict survival after resection of colorectal liver metastases.
Wong GYM; Bhimani N; Mol B; Diakos C; de Reuver P; Molloy MP; Hugh TJ
HPB (Oxford); 2022 Aug; 24(8):1316-1325. PubMed ID: 35093297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]